Mid-to Long-term Outcomes After Single Radiofrequency Ablation of Nontoxic and Toxic Thyroid Nodules
The Journal of Clinical Endocrinology & Metabolism · 22.04.2026 · 111 (5) · 1397-1407
DOI: 10.1210/clinem/dgaf611 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 04.11.2025. Verfasst von Harald Dobnig und 1 weiteren Autor:innen. Beteiligte Einrichtung: Thyroid Practice and Clinic for Radiofrequency Ablation and Minimally Invasive Interventions, Kumberg 8062, Austria. Hauptthemen laut MEDLINE: Thyroid Nodule, Radiofrequency Ablation, Neoplasm Recurrence, Local, Adenoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the mid- to long-term recurrence rates after a single radiofrequency ablation (RFA) of benign thyroid adenomas.
Design
Retrospective review of data collected in a standardized prospective database.
Setting
Single-center thyroid clinic in Austria.
Participants
Eight hundred ninety-six consecutive patients with either nontoxic nodules (n = 765) or toxic adenomas (n = 131).
Intervention
Mono- or bipolar RFA under local anesthesia. Main Outcome Measures Recurrence defined as increase in nodule size after RFA treatment by ≥50% from its smallest volume (nontoxic adenomas) or relapse of hyperthyroidism (toxic adenomas).
Results
Follow-up periods of 3 years or more were available for 437 nontoxic and 58 toxic adenomas. The median baseline volume was 10.1 mL [interquartile range (IQR) 5.5-20] for nontoxic and 7.2 mL (IQR 4.2-14.3) for toxic nodules. Solid or predominantly solid nodules comprised 81% and 93%, respectively. After 1, 3, and 5 years, the average nodule volume decreased by 79%, 82%, and 86% for nontoxic and by 84%, 88%, and 89% for toxic nodules, remaining stable afterwards. In 54 patients (7.1%) with nontoxic nodules, regrowth occurred, with a cumulative incidence rate of 17.3% over a maximum of 8 years. Among 15 patients (11.5%) with toxic adenomas, recurrence of hyperthyroidism was observed over 7 years (21.6% cumulative incidence). Fourteen of these patients became euthyroid after low-dose radioiodine treatment (n = 11) or a second RFA (n = 3). Documented complications included 2.3% moderate and 0.3% severe cases.
Conclusion
In our cohort, a single RFA treatment resulted in favorable mid- to long-term outcomes in 83% of nontoxic and 78% of toxic adenoma patients, with an acceptable complication rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thyroid Practice and Clinic for Radiofrequency Ablation and Minimally Invasive Interventions, Kumberg 8062, Austria.
- Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz 8010, Austria.
ORCID-Profile: Harald Dobnig, Karin Amrein
Zitieren
APA
Dobnig, H., & Amrein, K. (2026). Mid-to Long-term Outcomes After Single Radiofrequency Ablation of Nontoxic and Toxic Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism, 111(5), 1397-1407. https://doi.org/10.1210/clinem/dgaf611
Vancouver
Dobnig H, Amrein K. Mid-to Long-term Outcomes After Single Radiofrequency Ablation of Nontoxic and Toxic Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. 2026;111(5):1397-1407. doi:10.1210/clinem/dgaf611
BibTeX
@article{Dobnig2026,
author = {Dobnig, Harald and Amrein, Karin},
title = {Mid-to Long-term Outcomes After Single Radiofrequency Ablation of Nontoxic and Toxic Thyroid Nodules},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
volume = {111},
number = {5},
pages = {1397--1407},
doi = {10.1210/clinem/dgaf611}
}
EUVIMED